theravance.com (TBPH) - Book Value per Share

Symbol and logo of brand Theravance Biopharma (TBPH)

This price chart, serving as confirmation of the market valuation, demonstrates the price action of Theravance Biopharma (TBPH), whose respiratory product manufacturing facilities operate with high efficiency and regular equipment upgrades. The current figure is 5.61. The business relies on recognition from pulmonologists due to its high-quality inhalation products. Additionally, Theravance Biopharma (TBPH) generates revenue from partner royalties while developing therapies for infections and respiratory tracts.

TBPH Theravance Biopharma Inc Share Book Value (07/04/2022 - 10/10/2026)

Summary analytical data breakdowns for theravance.com (TBPH)

- current quotes and average value forecast:
Price Chart Theravance|TBPH - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Theravance Biopharma, Inc.|TBPH - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share Theravance Biopharma|TBPH - Net Asset Value|Market Capitalization to Book Value Ratio theravance.com|TBPH - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Theravance Biopharma|TBPH - Long-Term Debt to Capital|Short-Term Debt to Equity Theravance Biopharma, Inc.|TBPH - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Theravance Biopharma, Inc.|TBPH - Company Long-Term Liabilities|Company Short-Term Debts Theravance Biopharma|Quick Liquidity Indicator theravance.com
- earnings and multiples data:
TBPH - Final Profit
General company analysis:TBPH - Theravance
Manufactured products of Theravance Biopharma, Inc.

Book value per share reflects the actual tangible asset base of each security. By analyzing the fair book value of a share, an investor assesses the difference between the company's total assets and liabilities. The trend of this indicator is sensitive to asset revaluations and the accumulation of retained earnings. For Theravance Biopharma (TBPH), this metric confirms financial stability during the implementation of its strategy to receive royalties from GSK. Growth in this metric indicates the effective development of its own drug portfolio.

Competitor analysis

HLN - Net Assets per Single Share|Share Book Value KVUE|VRNA: Book Value per Share|jyongbio.com - Accounting Value of a Share|Net Assets per Single Share Ligand|Amneal Pharmaceuticals, Inc. - Share Book Value|Book Value per Share PRGO|ALVO (Alvotech Biopharmaceuticals) - Accounting Value of a Share|Book Value per Share LQDA (Liquidia Corporation)|Book Value per Share glpg.com GLPG|ANIP - Net Assets per Single Share|Accounting Value of a Share MNKD (MannKind Corp)|Amphastar (AMPH) - Net Assets per Single Share|Accounting Value per Share Pacira Corp|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share aquestive.com|Accounting Value per Share SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Accounting Value of a Share|Net Assets per Single Share Tonix Pharmaceuticals Inc. TNXP|SXT Pharmaceuticals (SXTC) - Net Asset Value per Share|EPRX: Accounting Value per Share|bioharvest.com - Book Price of a Share|EXOZ: Book Value per Share|Oramed Pharmaceuticals Inc. - Accounting Value of a Share|ENTX (Entera Bio Ltd) - Book Value per Share|Net Asset Value per Share MindWalk Therapeutics HYFT|Net Assets per Single Share ABVC BioPharma (ABVC)|CPIX (cumberlandpharma.com) - Accounting Value of a Share|Quantum BioPharma - Accounting Value per Share|Book Price of a Share FGEN (FibroGen Inc)|Telomir Pharma - Book Value per Share|Accounting Value of a Share RANI (Rani Therapeutics)|SNYR: Book Value per Share|Net Asset Value per Share Rallybio (RLYB)|Net Assets per Single Share Lexaria Bioscience Corp|PULM: Accounting Value of a Share|Book Value per Share PTHL|Book Value per Share aptorumgroup.com (APM)|Lyra Therapeutics, Inc. - Accounting Value per Share|Impact BioMedical, Inc. - Net Assets per Single Share|TNF Pharma - Book Value per Share|YCBD - Book Value per Share|PainReform Limited (PRFX) - Net Assets per Single Share|Equity per Share CYTO|LIPO (Lipella Pharmaceuticals) - Book Value per Share|Accounting Value per Share optinose.com (OPTN)|Book Value per Share PIRS|PROC - Net Asset Value per Share|Petros - Accounting Value per Share|Accounting Value of a Share QLI|Acelyrin, Inc. - Book Value per Share|TFFP: Net Assets per Single Share